Ottawa, Canada
Ottawa, Canada

Time filter

Source Type

Napa: May 10, 2017 – Bernard Gillery, Founder and Chairman of Eurodia Industrie of France, and one of the originators in the development of the Electrodialysis processes for Tartrate Stabilization, will be in Napa this week for the first OENODIA GLOBAL CONFERENCE. OENODIA, the Eurodia wine division which has a branch office in Napa, was created as a result of the development of an innovative solution for the Tartaric Stabilization of wine along with Monsieur Gillery’s interest in developing a range of exclusive and highly effective solutions tailored to the winemaking industry. OENODIA and its eco-processes, which guarantee quality treatments without any additives; Tartaric Stabilization by Electrodialysis, as well as membrane-based pH and alcohol adjustment, now operate in 12 countries across 5 continents. Partners from across the globe will join Monsieur Gillery in Napa next week to discuss the future of OENODIA, the company’s continued growth, their ongoing commitment to Research & Development and the new technologies they have in the pipeline. In December of last year, OENODIA announced the introduction of their new STARS XF, which combines single pass Crossflow with STARS Tartaric Stabilization. STARS XF is part of their newly expanded STARS line, which also includes STARS Stab for Tartrate Stabilization, and STARS pH for pH Adjustment. Another KeyNote Speaker joining Mr Gillery at the Conference will be Jean Luis Escudier, renowned expert in enology and former Director of the experimental unit of Pech Rouge-INRA France where, in collaboration with the Joint Research Unit for “science for the oenology”, Jean Luis was also involved in the development of the ED process which allows winemakers to eliminate the deposits in the wine while avoiding the addition of compound stabilizers. Bernard Gillery is the Founder & Chairman of Eurodia Industrie of France. Mr. Gillery is a Chemical Engineer with greater than 30 years of experience working with purification systems. Under Mr. Gillery’s leadership Eurodia has become a world-leader in liquid purification industrial processes, generating over 35 million euros in income in 2016, serving preeminent customers in the Agro-food and Biotech industries worldwide. Eurodia was initially established for the design, manufacturing and sales of electro-dialysis stacks to industries in Dairy and Water sectors. Today, Eurodia has expanded its sales and services to include customized turnkey process solutions combining innovative technologies such as electro dialysis, chromatography, ion exchange systems, and membrane filtration. OENODIA is the oenology division of Eurodia Industrie S.A, (France) one of the world’s leading specialists in membrane-based treatments for the agri-food industry. OENODIA®, provides membrane based eco-processes used for tartaric stabilization, acidification, de-acidification, cross-flow filtration and de-alcoholization of wines. A new OENODIA branch office, OENODIA NORTH AMERICA, opened in Napa in 2015. The location will provide direct support and service to the growing number of wineries utilizing the STARS (Specific Tartrate Removal System), STARS Ph and STARS Mobile Service. For more information about OENODIA, visit www.oenodia.us


News Article | May 22, 2017
Site: www.prnewswire.com

The all-new TET is prominently featured on the lower level of MiSci. The exterior of the theater features an interactive wall that allows visitors to engage in unique STEM activities. Once inside, the TET delivers a unique four-dimensional experience that engages multiple senses. It houses a state-of-the-art HD projection system with 3D viewing capabilities and enhanced space and lighting for a more immersive experience. The TET is the only theater in Michigan to incorporate "spark" effects without heat, smoke or pyrotechnics. Additionally, advanced viewing technology enables MiSci to live stream video footage to and from virtually anywhere in the world bolstering the facility's distance learning programs. "We're focused on empowering and enriching all children and all communities with STEM," said Dr. Tonya Matthews, Michigan Science Center president and CEO. "Our partnership with Toyota, and the TET, with its new technology, will help reach communities across Michigan and build a legacy and inspiration of STEM education for students, schools, and families." Toyota has made Michigan its hub for North American automotive research and development. Through its Ann Arbor-based, state-of-art product development facility, the company has access to a talent pool of experienced engineers. "Because of places like the Michigan Science Center, there will be a good number of students who are inspired to go into science, inspired to think to the future and do great things," said Detroit native, Chris Reynolds, executive vice president of Corporate Resources, chief diversity officer & managing officer at Toyota Motor Corporation. The theater's public grand opening is Saturday, May 27 to celebrate, MiSci is offering free general admission and TET tickets for the entire weekend to the world debut of the National Geographic film "Extreme Weather 4D," exclusively produced for MiSci. The film is an interactive experience that transports visitors as they discover the dynamic and complex forces shaping our planet - and the surprising connections that help us understand and adapt to our ever-changing weather. Pre-registration is required and can be found at Mi-Sci.org "We are excited to open our doors and allow the community to experience this one-of-a-kind experience for free and want to thank Toyota for their continued support," added Matthews. About the Michigan Science Center The Michigan Science Center inspires nearly 300,000 curious minds of all ages every year through STEM (science, technology, engineering, and math) discovery, innovation and interactive education in Detroit and across the state of Michigan. As the STEM hub of the state, we focus on developing and introducing expanded education programs, exhibits, and initiatives that enable us to empower and enrich all children and all communities with STEM. Through our Traveling Science Program and distance learning initiative, we are expanding beyond our Detroit-based facility, with a goal of reaching all 83 counties of Michigan. With Toyota's 4D Engineering Theater, live stage shows, Michigan's only IMAX® Dome Theatre, a Planetarium, lab activities, 250+ hands-on exhibits, and more, there are dozens of ways to customize your MiSci visit. The Michigan Science Center is a 501(c)(3) nonprofit organization and does not receive support from the city of Detroit or the state of Michigan. For more information, please call 313.577.8400 or visit the website, Mi-Sci.org. About Toyota  Toyota (NYSE: TM) has been a part of the cultural fabric in the U.S. and North America for 60 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands. During that time, Toyota has created a tremendous value chain as our teams have contributed to world-class design, engineering, and assembly of more than 33 million cars and trucks in North America, where we operate 14 manufacturing plants (10 in the U.S.) and directly employ more than 46,000 people (more than 36,000 in the U.S.).  Our 1,800 North American dealerships (nearly 1,500 in the U.S.) sold almost 2.7 million cars and trucks (2.45 million in the U.S.) in 2016 – and about 85 percent of all Toyota vehicles sold over the past 15 years are still on the road today. Toyota Motor North America Research & Development (TMNA R&D) aims to redefine next-generation cars as not simply a form of transportation, but as a fully connected vehicle. In fact, Toyota is the leader in automotive patents, including autonomous vehicle patents (over 2,000). Centered in Ann Arbor, Michigan, Toyota puts the brightest thinkers from all across America together to focus on letting people live more safely and comfortably. Globally, Toyota spends approximately $1 million per hour on R&D to ensure that Toyota rapidly and continuously develops cutting-edge, high-quality, and appealing vehicles. To date, Toyota has contributed more than $900 million to American nonprofit groups.  For more information about Toyota's contributions in the U.S., visit http://www.toyota.com/about To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/michigan-science-center-unveils-new-144m-toyota-4d-engineering-theater-300461427.html


Lavelle continued, "Throughout the year, we set in motion a series of events to streamline operations and leverage synergies within our organization.  These efforts, along with improvements in our supply chain led to a gross margin improvement in Fiscal 2017 of 90 basis points and a reduction in operating expenses of $5.6 million.  Additionally, we focused R&D investment dollars on next generation products, particularly within our Premium Audio and Automotive segments.  We have seen some of the results in our Fiscal 2017 financial performance and expect Fiscal 2018 will build on the momentum.  Our foundation is stronger, as are our offerings, and we believe VOXX is positioned well to generate further top- and bottom-line improvements." Fiscal Fourth Quarter Comparisons (for the periods ended February 28, 2017 and February 29, 2016) Net sales for the Fiscal 2017 fourth quarter were $167.4 million, compared to $169.7 million reported in the comparable year-ago period, a decline of $2.3 million or 1.4%. The gross margin for the Fiscal 2017 fourth quarter came in at 30.3% as compared to 27.6% for the same period last year, an increase of 270 basis points.  Driving this improvement were higher gross margins in the Automotive segment. Operating expenses for the Fiscal 2017 fourth quarter were $50.3 million as compared to $54.3 million in the Fiscal 2016 fourth quarter, a reduction of $4.1 million or 7.5%. Included in the Fiscal 2016 fourth quarter operating expenses are impairment charges of $2.9 million that did not repeat in Fiscal 2017.  The remaining decline is primarily due to lower labor costs, including a reduction in research and development expenses and a modest decline in selling expenses. The Company reported operating income of $0.4 million in its Fiscal 2017 fourth quarter as compared to an operating loss of $7.5 million in the comparable year-ago period.  The $8.0 million year-over-year improvement was driven by higher gross margins and lower total operating expenses, as noted above.  Net loss attributable to VOXX International Corporation for the Fiscal 2017 fourth quarter was $0.1 million or $0.00 per basic and diluted share, as compared to a net loss attributable to VOXX International Corporation of $5.4 million or a loss of $0.22 per basic and diluted share in the Fiscal 2016 fourth quarter. Earnings before interest, taxes, depreciation and amortization ("EBITDA") for the Fiscal 2017 fourth quarter was $8.0 million as compared to an EBITDA loss of $1.0 million reported in the Fiscal 2016 fourth quarter, an improvement of $9.0 million.  Adjusted EBITDA was $8.1 million as compared to Adjusted EBITDA of $2.0 million for the comparable Fiscal 2017 and 2016 fourth quarter periods, representing an increase of $6.1 million. FY17 vs. FY16 Comparisons (for the twelve-months ended February 28, 2017 and February 29, 2016) Fiscal 2017 net sales were $681.0 million compared to $680.7 million reported in the comparable year-ago period, an increase of $0.3 million. The gross margin for Fiscal 2017 was 29.6% as compared to 28.7% for Fiscal 2016, an increase of 90 basis points.  Automotive segment gross margins were 30.9%, an increase of 150 basis points; Premium Audio segment gross margins were 33.0%, a decline of 20 basis points; and Consumer Accessories segment gross margins were 23.6%, a decline of 70 basis points. Operating expenses in Fiscal 2017 were $201.7 million compared to $207.3 million in Fiscal 2016, a reduction of $5.6 million.  Selling, general and administrative expenses of $156.1 million declined by $3.8 million or 2.4%, due to continued cost control measures throughout the Company.  Engineering and technical support expenses of $45.6 million increased by $8.1 million year-over-year, as the Company continued to invest in Research & Development to support various Automotive OEM projects and new product launches within the Premium Audio segment.  Additionally, Fiscal 2016 included $9.1 million of intangible asset impairment charges related to certain trademarks of the Company and $0.8 million of acquisition-related costs that did not repeat in the current year. The Company reported an operating loss in Fiscal 2017 of $0.2 million as compared to an operating loss of $11.6 million in Fiscal 2016, a year-over-year improvement of $11.4 million.  The Company reported net income attributable to VOXX International Corporation of $4.4 million or net income per basic and diluted share of $0.18 in Fiscal 2017.  This compares to a net loss attributable to VOXX International Corporation of $2.7 million or a loss per basic and diluted share of $0.11 in Fiscal 2016. EBITDA for Fiscal 2017 was $30.1 million as compared to EBITDA of $18.8 million reported in Fiscal 2016, an improvement of $11.3 million.  Adjusted EBITDA was $30.9 and $24.8 million for the comparable Fiscal 2017 and 2016 years, an improvement of $6.0 million. EBITDA, Adjusted EBITDA and Diluted Adjusted EBITDA per common share are not financial measures recognized by GAAP.  EBITDA represents net income (loss), computed in accordance with GAAP, before interest expense and bank charges, taxes, and depreciation and amortization. Adjusted EBITDA represents EBITDA adjusted for stock-based compensation expense, impairment charges, certain foreign currency remeasurements, restructuring charges, as well as costs and bargain purchase gains relating to our acquisitions. Depreciation, amortization, stock-based compensation, bargain gains and impairment charges are non-cash items. Diluted Adjusted EBITDA per common share represents the Company's diluted earnings per common share based on Adjusted EBITDA. We present EBITDA, Adjusted EBITDA and Diluted Adjusted EBITDA per common share in this Form 10-K because we consider them to be useful and appropriate supplemental measures of our performance. Adjusted EBITDA and diluted adjusted earnings per common share help us to evaluate our performance without the effects of certain GAAP calculations that may not have a direct cash impact on our current operating performance. In addition, the exclusion of certain costs or gains relating to non-recurring events allows for a more meaningful comparison of our results from period-to-period. These non-GAAP measures, as we define them, are not necessarily comparable to similarly entitled measures of other companies and may not be an appropriate measure for performance relative to other companies. EBITDA, Adjusted EBITDA and Diluted Adjusted EBITDA per common share should not be assessed in isolation from, are not intended to represent, and should not be considered to be more meaningful measures than, or alternatives to, measures of operating performance as determined in accordance with GAAP. The Company will be hosting its conference call on Tuesday, May 16, 2017 at 10:00 a.m. ET.  Interested parties can participate by visiting www.voxxintl.com, and clicking on the webcast in the Investor Relations section or via teleconference (toll-free number: 877-303-9079; international: 970-315-0461 / conference ID: 12837314). VOXX International Corporation (NASDAQ: VOXX) has grown into a worldwide leader in Automotive, Consumer Electronics, Consumer Accessories and Premium Audio.  Today, the Company has an extensive distribution network that includes power retailers, mass merchandisers, 12-volt specialists and most of the world's leading automotive manufacturers.  The Company has an international footprint in Europe, Asia, Mexico and South America, and a growing portfolio, which now comprises over 30 trusted brands. Among the Company's brands are Klipsch®, RCA®, Invision®, Jensen®, Audiovox®, Terk®, Acoustic Research®, Advent®, Code Alarm®, Car Connection®, 808®, AR for Her®, Prestige®, EyeLock, Hirschmann Car Communication®, Jamo®, Energy®, Mirage®, Mac Audio®, Magnat®, Heco®, Schwaiger®, Oehlbach®, and Incaar™.  For additional information, please visit our Web site at www.voxxintl.com. Except for historical information contained herein, statements made in this release that would constitute forward-looking statements may involve certain risks and uncertainties. All forward-looking statements made in this release are based on currently available information and the Company assumes no responsibility to update any such forward-looking statements. The following factors, among others, may cause actual results to differ materially from the results suggested in the forward-looking statements. The factors include, but are not limited to risks that may result from changes in the Company's business operations; our ability to keep pace with technological advances; significant competition in the automotive, premium audio and consumer accessories businesses; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; non-availability of product; excess inventory; price and product competition; new product introductions; foreign currency fluctuations and concerns regarding the European debt crisis; restrictive debt covenants; the possibility that the review of our prior filings by the SEC may result in changes to our financial statements; and the possibility that stockholders or regulatory authorities may initiate proceedings against VOXX International Corporation and/or our officers and directors as a result of any restatements. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended February 28, 2017. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/voxx-international-corporation-reports-its-fiscal-2017-fourth-quarter-and-year-end-financial-results-300457782.html


News Article | May 16, 2017
Site: www.thedrinksbusiness.com

The inland region enjoys a typical continental climate, and most vineyards are located either on on terraced hills or in the foothills of the mountain range in the southeastern part of the province. Its wine production in 2015 was 4,700 kilolitres, far below Xinjiang’s production. Leading wineries in the region include Grace Vineyard, Qingxu and Château Rongzi. Located 800 to 900 metres above sea level, Grace Vineyard in Taigu county, 40 kilometres south of the provincial capital Taiyuan, is leading the pack, producing wines from Bordeaux blends to lesser known varieties, such as Aglianico and Marselan. The winery takes up about 50% market share in the local province in terms of wine sales, with the rest being Changyu and Great Wall, according to a report by Hua Xia Wine News. While high quality winemaking is already evident, there remains an experimental element as winemakers are trying to find consistency in quality. The local silty sand soil provides vines with good drainage and conductivity but with strong winds blowing down from Shanxi Plateau, it is also subject to erosion. Based on the soil composition and analysis, starting from 2006, Grace Vineyard started to plant Aglianico and Marselan, and additional new varieties have been planted since 2013 in small quantities including Saperavi, Sangiovese, Tempranillo, Nebbiolo, Sauvignon Blanc and Pinot Noir. Its vineyard sites in Taigu, for example, enjoy an average of 190 free-frost days annually, the winery says, but diseases still threaten production, which are mainly spider mites and trunk disease. In recent years, the winery has expanded its foothold and purchased more vineyard sites in Ningxia and neighbouring Shaanxi provinces. Judy Chan, CEO of the family-owned boutique winery, chats to dbHK about making wines in China, how Chardonnay differs in Shanxi and Ningxia provinces as well as the challenges of managing her winery. Is winemaking a new concept in Shanxi province? From technical point of view, why did you choose Shanxi over other regions? It was 20 years ago (this year is Grace Vineyard’s 20th Anniversary). I believe that each region in China (above the Yellow River) has its own character. The key is to find which grape to grow where. For instance, I believe Chardonnay is a great one for Shanxi. It has better acidity than Ningxia. Shanxi has a very large difference between day and night time temperature. Our sandy soil is well drained and we have plenty of sunshine. As a Chinese winemaker, what are the biggest common misconceptions the international trade have about winemaking in China? I believe most people still think that China only produces low-end wines. It was the case in the past, but more and more producers are focusing on producing better quality wines. We put a lot of effort into Research & Development, like what to plant, where to plant, what wine to make. Without an AOC-like system, we have more freedom to experiment. Compared with other wine regions in the world, what are the problems unique to winemaking in China? We have to bury the vines in winter, which is costly, labor intensive and affects the way we prune. Also, we tend to have summer rain in August which can be a big problem in certain years. Managing Grace Vineyard, from first founding the winery till now, what was the biggest challenge you encountered? It seems like we just keep having new challenges every year. I guess this is what keeps me going every day. Grace Vineyard was one of the few wineries in China really that focused on producing quality Chinese wine. It was a concept unheard of and it wasn’t easy to convince people that we walked the walk, talked the talk. Also, many people at that time didn’t even know we produced wines in China. I remember we were at a wine exhibition back in 2003, a guy came and wanted to taste the wine.  He asked where the wine was from. When I told him it was from China, he turned around and left. Now, it’s very different. Partially it’s because many people have heard of Grace Vineyard and are curious about wine from China. We have been one of the busiest booths at Vinexpo Hong Kong for several years in a row.


Volvo Cars, the premium carmaker, has announced a close partnership with Google, one of the world's largest technology companies, to develop the next generation of its award-winning in-car infotainment and connectivity solution based on Android, offering access to a wide array of apps and services. It will launch on new Volvo models within two years. To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8103651-volvo-cars-google-android-connected/ The partnership promises to revolutionise how Volvo customers engage and interact with their cars. The large catalogue of popular Android apps - developed by Google, Volvo, or third party app developers - will offer connected and predictive services in and around the car. "We are making an important strategic step with the Google partnership. Google's platform and services will enhance the user experience by enabling more personalisation possibilities, while Android will offer increased flexibility from a development perspective," said Henrik Green, Senior Vice President Research & Development at Volvo Car Group. Volvo Cars' partnership with Google reflects the ongoing convergence between the automotive and technology industries as cars become increasingly connected. Volvo believes smart partnerships are the future for the car industry. Using Android as the base operating system will increase speed and flexibility in the development and offer its customers the ability to personalize the connected in-car experience. "We're thrilled to partner with Volvo to bring Android into their next generation connected cars," said Patrick Brady, Vice President of Android Engineering at Google. "This partnership gives us the opportunity to deliver a more seamless experience to Volvo drivers through a full-featured infotainment platform and rich ecosystem of Android applications and Google services." "With the advent of Android we will embrace a rich ecosystem while keeping our iconic Volvo user interface. We will offer hundreds of popular apps and the best integrated experience in this broad, connected environment," said Henrik Green. Volvo is also collaborating with Google on another initiative to update recent Volvo models by adding Google Local Search, a location based service application. This will be released through an update to customers with Sensus Navigation. Further details on the partnership and Android OS will be announced at Google's annual tech show, Google I/O on May 17. Volvo Cars most recently launched a replacement to its bestselling medium size SUV, the XC60 at the Geneva Motor Show. It is set to reveal a smaller SUV, the XC40, later this year. A picture accompanying this release is available through the PA Photowire. It can be downloaded from http://www.pa-mediapoint.press.net or viewed at http://www.mediapoint.press.net or http://www.prnewswire.co.uk.


News Article | May 15, 2017
Site: www.marketwired.com

ST. JOHN'S, NL--(Marketwired - May 15, 2017) - Kraken Sonar Inc. ("Kraken") (TSX VENTURE: PNG) is pleased to announce that its wholly-owned subsidiary, Kraken Sonar Systems Inc. has been awarded a non-refundable financial contribution of $745,950 by the Research & Development Corporation (RDC) of Newfoundland and Labrador. The funding will support development of Kraken's ThunderFish™ Autonomous Underwater Vehicle (AUV) program. The ThunderFish™ program will combine smart sonar, laser and optical sensors, advanced pressure tolerant battery and thruster technologies and cutting edge artificial intelligence algorithms integrated onboard a cost effective 6,000 metre depth rated AUV. Karl Kenny, President and CEO of Kraken said, "We are very grateful to RDC for their support of our efforts and appreciate their thorough review of our development program. This funding will help maintain the excellent momentum we have been building over the past two years in underwater robotics." "Technological innovations in sensors, high performance computing and robotics now enable next generation underwater vehicles that are highly autonomous, cost effective, light weight and easier to operate. We look forward to continuing to develop advanced marine technologies and products to meet the ever-evolving demands of our growing customer base." ABOUT THE GLOBAL AUV MARKET The global AUV market is experiencing an advanced rate of growth due to increasing demand in military, commercial and scientific research applications. Significant growth is expected in the commercial sector, predominately from oil and gas operators - despite the volatility of oil prices. There has also been substantial interest in the technology from the offshore renewable energy sector, as operators have begun to understand the cost saving potential of AUVs for inspection of underwater assets. Research from industry analysts Technavio forecasts that the global AUV market is expected to grow from US$600 million in 2015 to over US$2 billion by 2020. The World AUV Market Forecast from Douglas-Westwood covers all key commercial themes relevant to companies across the value chain in all AUV sectors. The report considers the prospective demand for AUVs in the commercial, military and research sectors over the next several years. Unit demand is expected to increase over the forecast at a CAGR of 10%, with all sectors seeing growth due to increased utilisation of AUV technology. ABOUT RDC AND ITS FUNDING OF KRAKEN RDC is a provincial Crown corporation responsible for improving Newfoundland and Labrador's research and development (R&D) performance. RDC works with R&D stakeholders including business, academia, and government agencies and departments to make strategic investments in highly qualified people, R&D infrastructure, and innovative research. Additional information about RDC can be found at: www.rdc.org. Kraken's funding contribution was provided under RDC's SensorTECH program, which supports sensor research, development and demonstration in simulated and real operating environments. Research and development conducted under this program helps solve local technical challenges and contributes to the development of new or improved products and services with sensor-related technologies such as radar, acoustics, optics, sonar and signal processing that can be exported around the world. The SensorTECH funding will be used during 2017 and 2018 to help develop Kraken's THUNDERFISH AUV platform. Kraken Sonar Inc. (TSX VENTURE: PNG) is a marine technology company, founded in 2012, that is dedicated to the production and sale of software-centric sensors and next-generation underwater robotic systems. The company is headquartered in St. John's, Newfoundland with offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia. For more information, please visit www.krakensonar.com and www.krakenrobotik.de Certain information in this news release constitutes forward-looking statements. When used in this news release, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. In particular, this news release contains forward-looking statements with respect to, among other things, business objectives, expected growth, results of operations, performance, business projects and opportunities and financial results. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such statements reflect the Company's current views with respect to future events based on certain material factors and assumptions and are subject to certain risks and uncertainties, including without limitation, changes in market, competition, governmental or regulatory developments, general economic conditions and other factors set out in the Company's public disclosure documents. Many factors could cause the Company's actual results, performance or achievements to vary from those described in this news release, including without limitation those listed above. These factors should not be construed as exhaustive. Should one or more of these risks or uncertainties materialize, or should assumptions underlying forward-looking statements prove incorrect, actual results may vary materially from those described in this news release and such forward-looking statements included in, or incorporated by reference in this news release, should not be unduly relied upon. Such statements speak only as of the date of this news release. The Company does not intend, and does not assume any obligation, to update these forward-looking statements. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Neither the TSX Venture Exchange Inc. nor its Regulation Services Provide (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


News Article | May 15, 2017
Site: www.prnewswire.com

•     •         The market size for pipe coatings is projected to reach USD 14.42 billion by 2021, at a CAGR of 4.7% from 2016 to 2021 •     •         The global pipe coatings industry is expected to grow due to the increasing demand in economies such as China, India, South Korea,  Africa, Mexico, the U.S., Germany, Brazil, and Argentina, among others. •     •         North America, the largest market and South America, the fastest growing market for pipe coatings •     •         This is majorly due to the increasing demand for oil & gas in the region. •     •         The demand has promoted E&P activities for onshore and offshore reserves, which is facilitating the demand for pipelines and hence driving the pipe coatings market. High demand from oil & gas industry is expected to drive the pipe coatings market The market size for pipe coatings is projected to reach USD 14.42 billion by 2021, at a CAGR of 4.7% from 2016 to 2021. Increasing demand from the oil & gas industry is the major driver for the pipe coatings market. The global pipe coatings industry is expected to grow due to the increasing demand in economies such as China, India, South Korea, Africa, Mexico, the U.S., Germany, Brazil, and Argentina, among others. The fluctuating demand from the oil & gas industry is a major concern for the pipe coatings market. Fusion Bonded Epoxy (FBE) coating is the fastest-growing type of pipe coating. This is due to its high adherence to steel pipes and the fact these are resistant to chemical and physical stress. These coatings are widely used in various industries as they also help to improve the flow efficiency of the contents in the pipes. North America, the largest market and South America, the fastest growing market for pipe coatings North America is the largest market for pipe coatings globally, with the U.S. being the leading market in this region, which is attributed to the large oil & gas industry. The increasing demand for shale gas is driving the market in this region. Further, transportation, distribution and Exploration & Production (E&P) activities in the oil & gas industry are expected to drive the market. South America is estimated to be the fastest growing market for pipe coatings during the forecast period, 2016-2021. This is majorly due to the increasing demand for oil & gas in the region. The demand has promoted E&P activities for onshore and offshore reserves, which is facilitating the demand for pipelines and hence driving the pipe coatings market. This study has been validated through primary interviews conducted with various industry experts globally. These primary sources have been divided into three categories: by company; by designation; and by region. The report also includes company profiles and competitive strategies adopted by the major market players such as PPG Industries, Inc. (U.S.), Akzo Nobel N. V. (The Netherlands), The Sherwin-Williams Company (U.S.), The Valspar Corporation (U.S.), Axalta Coating Systems Ltd. (U.S.), Wasco Energy Ltd. (Malaysia), Arkema S.A. (France), Shawcor Ltd. (Canada), The 3M Company (U.S.), and Specialty Polymer Coatings, Inc. (Canada). This research report categorizes the market for pipe coatings based on type, form, end-use industry, and region. It forecasts revenue growth and includes an analysis of trends in each of the submarkets. These segments are further described in detail with their subsegments in the report with value and volume forecasts till 2021. It also includes company profiles and competitive strategies adopted by the major players in the global pipe coatings market. From an insight perspective, this research report has focused on various levels of analysesindustry analysis (industry trends), market ranking of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the pipe coatings market; high-growth regions; and market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: Market Penetration: Comprehensive information on pipe coating types offered by the top market players Product Development/Innovation: Detailed insights on emerging technologies, Research & Development (R&D) activities, and new product launches in the pipe coatings market Market Development: Comprehensive information on lucrative emerging markets  the report analyzes the pipe coatings market across regions Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the pipe coatings market Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the pipe coatings market Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pipe-coatings-market-to-reach-1442-billion-usd-by-2021-300457624.html


New Roles for Several Executive Management Team Members PERTH, AUSTRALIA and GREER, SC--(Marketwired - May 15, 2017) - Alexium International Group Limited ("Alexium," "the Company,") ( : AJX) (NASDAQ Designation: AXXIY) has affirmed previously announced management succession and highlighted new roles within the Company for several team members as the focus moves to increased commercial product sales across flame retardant (FR) formulations and phase change material (PCM) cooling formulations. The streamlining of Alexium's organizational structure will capitalize on the strength of Alexium's existing management team as Dr. Dirk Van Hyning transitions into the CEO role on July 1, 2017. Dr. Van Hyning, said, "The planned succession changes enable us to capitalize on our growing reputation and brand awareness in both the FR and PCM markets where end use customers are now requesting environmentally friendly and performance enhancing Alexium formulations, by name." Nicholas Clark, currently CEO and Executive Director, will continue his role on the board as Executive Director Strategy with a focus on strategy beginning July 1 at an adjusted lower salary commensurate with his new duties. In this capacity, Mr. Clark will oversee the Company's relations with U.S. Government departments across both defense and commercial sectors and facilitate the Company's anticipated listing on the NASDAQ. Gavin Rezos, currently Executive Chairman will transition to Non-Executive Chairman at an adjusted lower salary commensurate with his new duties on July 1. He will retain his current primary responsibility as Chairman of the Board of Directors, overseeing corporate governance and liaising between the Board and management. Aaron Krech, while retaining the role of Chief Financial Officer, will assist Dr. Van Hyning by assuming additional responsibility for operational efficiencies throughout the Company's global business and ensuring high-quality customer service. Prior to becoming Alexium's CFO in 2015, Mr. Krech was Head of Corporate Services at Alexium. Dr. Robert Brookins' role recently expanded as VP of Research & Product Development, with the consolidation of Product Development and Research & Development into one department, earlier this year. Prior roles at Alexium included Chief Technology Officer and Head of Research. Dr. Brookins' previous work at the Air Force Research Laboratory at Tyndall AFB in Florida, experience in organic synthesis, materials chemistry, and chem/bio protection, are just a few examples of the expertise Dr. Brookins brings to this senior position across the full range of our products. Brian Enlow assumed the role of VP of Finance earlier this year. Previously Alexium's Financial Reporting Manager, Brian's professional background includes public accounting, both audit and taxation, as well as corporate accounting roles focusing on financial reporting and cost accounting. Mr. Enlow's responsibilities include the day-to-day fiscal management of the business, management of the finance team and responsibility for all aspects of budget management, auditing, and financial reporting. Nick Clark, CEO of Alexium, said, "One of my main focuses has been placing the right people in the right roles. I am confident that Alexium's very experienced team will help the Company grow in its existing markets while opening up new markets for its specialty chemicals. We have already begun to benefit from this global expansion, with quarterly revenues increasing 92 percent quarter on quarter in the third quarter of financial year 2017, with higher gross margins each quarter. I look forward to Dirk guiding the company into the next phase of growth and achieving new milestones in product development and sales, as well as working with Dirk and the team, in my new role as Executive Director Strategy, to help pave the way for US Government related opportunities." Gavin Rezos, Chairman, said, "Alexium has reached a level of maturity and depth of executive staff to enable greater specialization within our management to capitalize on the many opportunities being presented for Alexium's award winning products. Our new facility in Greer has allowed faster response times to customer needs and fostered a strong cohesive management approach to rapidly growing sales, and product fulfillment needs. We are confident that Dirk and his team will drive increasing shareholder value, as our Alexium brand awareness continues to increase across different market sectors." About Alexium International Group Limited: Alexium International Group Limited (ASX: AJX, AJX: AX, Nasdaq Designation: AXXIY) holds proprietary patent applications for novel technologies developed to provide flame retardancy for a wide range of materials. These environmentally friendly flame retardants have applications for a number of industries and can be customized. Further, Alexium has developed products for a range of other applications including phase-change materials, water repellents, antimicrobials, and combinations thereof. Alexium also holds patents for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti- microbial treatments. Applications under development include but are not limited to textiles, packaging, electronics, and building materials. Alexium's chemical treatments are currently marketed under the Alexiflam™, Alexiflam FR™, Alexiflam SYN™, Alexiflam NF™, Alexiflam AD™, Alexiflam PB™, and Alexicool™ brand names. For additional information about Alexium, please visit www.alexiuminternational.com.


CASTRES, Frankrijk--(BUSINESS WIRE)--Pierre Fabre, de op één na grootste Franse particuliere farmaceutische groep, heeft vandaag de ondertekening van een definitieve koopovereenkomst aangekondigd om diverse activa te verwerven van het biotechnologisch bedrijf Igenica Biotherapeutics, gevestigd in Burlingame, Californië, Verenigde Staten. De overeenkomst omvat innovatieve immunotherapieën die gericht zijn op immuniteitscontrolepunten die de resistentie tegen bestaande immunotherapieën kunnen keren. Het meest geavanceerde actief is momenteel in een preklinische fase en wordt naar verwachting in de komende 2 tot 3 jaar toegediend aan patiënten. De overeenkomst omvat ook een reeks vroegtijdige ontdekkingsdoelstellingen. “Deze overeenkomst is in lijn met recente samenwerkingen ondertekend door Pierre Fabre met biotechnologiebedrijven en academische laboratoria op het gebied van oncologie en dermatologie en bevestigt onze Research & Development-dynamiek via externe partners” aldus Laurent Audoly, hoofd van Pierre Fabre Pharmaceuticals R&D. Over Igenica Biotherapeutics Igenica Biotherapeutics is gericht op de ontdekking en ontwikkeling van antilichamen op het gebied van immuun-oncologie en antilichaam-drugconjugaten (ADC's) voor de behandeling van kanker. Dit bedrijf ondersteunt het spectrum van ADC-ontwikkeling volledig, van een klinisch relevante benadering ten aanzien van het doel en de ontdekking van functionele antilichamen, tot de creatie van ADC's, wat de ontwikkeling en de levering van effectieve therapieën aan patiënten versnelt. Robert Schreiber, Ph.D* was in 2009 mede-oprichter van Igenica. Het bedrijf wordt geleid door een bewezen team van leiders die succes hebben getoond op het gebied van de ontdekking van antilichamen, klinische ontwikkeling en commercialisering. *(Bijzonder hoogleraar Pathologie en Immunologie, hoogleraar Moleculaire Microbiologie, Washington University School of Medicine) Over Pierre Fabre Pierre Fabre is een Frans particulier farmaceutisch en dermo-cosmeticabedrijf dat in 1962 opgericht werd door dhr. Pierre Fabre. De omzet van het bedrijf bedroeg ruim 2,28 miljard euro in 2016, verspreid over 130 landen. Het bedrijf is gestructureerd rond twee divisies: Farmaceutische producten (voorgeschreven medicijnen, consumentengezondheidszorg) en Dermo-cosmetica (waaronder het in Europa en Azië toonaangevende merk Eau Thermale Avène). Pierre Fabre heeft wereldwijd ongeveer 13.000 mensen in dienst en heeft dohterondernemingen in 47 landen. In 2016 wees het bedrijf 14% van de farmaceutische verkoop toe aan R&D, met een focus op 4 therapeutische gebieden: oncologie, dermatologie, CNS en consumentengezondheidszorg. Via de controlerende onderneming Pierre Fabre Participations van de groep is Pierre Fabre voor 86% in handen van de Pierre Fabre Foundation, een sinds 1999 erkende organisatie van openbaar belang. Tot 8,2% van de resterende aandelen zijn in handen van de werknemers van de onderneming en het resterende saldo wordt gehouden als ingekochte eigen aandelen. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.


CASTRES, France--(BUSINESS WIRE)--Pierre Fabre, the 2nd largest French private Pharmaceutical group, today announced the signature of a definitive purchase agreement to acquire several assets from the biotechnology company Igenica Biotherapeutics, based in Burlingame, California, USA. The agreement includes innovative immunotherapies targeting immune checkpoints that may reverse the resistance to existing immuno therapies. The most advanced asset is currently at preclinical stage and is expected to be administered to patients in the coming 2 to 3 years. The agreement also comprises a series of early discovery targets. “This agreement is in line with recent collaborations signed by Pierre Fabre with biotechnology companies and academic laboratories in the fields of oncology and dermatology and confirms our Research & Development dynamic through external partners” said Laurent Audoly, Head of Pierre Fabre Pharmaceuticals R&D. Frédéric Duchesne, Pharmaceutical Division Chief Executive Officer at Pierre Fabre added, “Pierre Fabre’s know-how in oncology is based on more than 30 years of experience. We have two recognized research and development centers with dedicated teams that work closely together to developing medicines for patients living with cancer. This new deal reinforces our position to participate in the revolution of targeted biotherapies and reinforce our commitment to bring substantial value to patients”. Under the terms of the agreement, Pierre Fabre has acquired the full property of the assets. The financial terms of the agreement are not disclosed. “We are very pleased that Pierre Fabre will clinically develop Igenica’s most advanced immune oncology asset for patients suffering from cancer ”said Edward van der Horst, Senior Director of Igenica’s Preclinical Drug Development. About Igenica Biotherapeutics Igenica Biotherapeutics is focused on the discovery and development of antibodies in the field of immune-oncology and antibody-drug conjugates (ADCs) for the treatment of cancer. This company fully powers the ADC development spectrum from a clinically relevant approach to target and functional antibody discovery to ADC creation, accelerating development and the delivery of effective therapies to patients. Co-founded in 2009 by Robert Schreiber, Ph.D*. Igenica is led by a proven team of leaders that have demonstrated success in antibody drug discovery, clinical development and commercialization. *(Alumni endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology, Washington University School of Medicine) About Pierre Fabre Pierre Fabre is a French private pharmaceuticals and dermo-cosmetics company founded in 1962 by Mr. Pierre Fabre. Its turnover reached over 2.28 billion Euros in 2016, spread over 130 countries. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the Europe and Asia market-leader Eau Thermale Avène brand). Pierre Fabre employs some 13,000 people worldwide and owns subsidiaries in 47 countries. In 2016, the company allocated 14% of its pharmaceuticals sales to R&D with a focus on 4 therapeutic areas: oncology, dermatology, CNS and consumer health care. Pierre Fabre Laboratories have always developed durable and valuable scientific partnerships with innovators from public research institutions (CRNS, Inserm...), faculties and universities (Ecole Polytechnique de Lausanne, Université de Saclay...), international pharmaceutical laboratories (Allergan, Abbvie, Maruho...) and biotech companies (Array BioPharma, AbCheck, Cellectar...). Through the Group’s controlling company Pierre Fabre Participations, Pierre Fabre is 86% owned by the Pierre Fabre Foundation, a recognized public-interest organization since 1999. Up to 8.2% of the remaining shares are held by the company’s employees and the remaining balance is held as treasury stock. To find out more about Pierre Fabre, please go to www.pierre-fabre.com

Loading Research & Development collaborators
Loading Research & Development collaborators